When was Novotech founded?

Novotech was founded in 2002 and raised its 1st funding round 11 years after it was founded.

Where is Novotech located?

Novotech is headquartered in Sydney, Australia. It is registered at CLEMENCEAU AVENUE Pincode : 239920.

How many employees does Novotech have?

As of Jun 30, 2026, the latest employee count at Novotech is 2148.

Is Novotech a funded company?

Novotech is a funded company, having raised a total of $255M across 5 funding rounds to date. The company's 1st funding round was a $***** PE round, raised on Apr 30, 2013.

How much is Novotech worth?

The last known valuation of Novotech was $***** as of Jan 19, 2022.

When was the latest funding round of Novotech?

Novotech's latest funding was a $***** Seed round on Mar 31, 2025, with participation from 3 investors.

What is the annual revenue of Novotech?

Annual revenue of Novotech is between $100M and $500M as on Dec 31, 2024

Where does Novotech rank among its competitors?

Novotech ranks 1st amongst 162 active competitors, of which 18 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Novotech, which secured an undisclosed amount in Mar, 2025.

Who are the top competitors of Novotech?

Novotech's top competitors include Concert AI, Bioptimus and Dotmatics. Among them, Novotech secured the most recent funding round in March, 2025.

Novotech - 2026 Company Profile, Funding, Competitors & Financials

Novotech is an acquired company based in Sydney (Australia), founded in 2002. It operates as a Provider of clinical research services across all trial phases and therapeutic areas. Novotech has raised $255M in funding, with last known valuation of $*****. The company has 162 active competitors, including 18 funded and 25 that have exited. Its top competitors include companies like Concert AI, Bioptimus and Dotmatics.

Company Details

Provider of clinical research services across all trial phases and therapeutic areas. It offers services including medical and regulatory consulting, patient recruitment, site selection, early phase trials, clinical operations, project management, site management, biometrics, data management, virtual clinical trials, real-world data analysis, and laboratory services. It also provides specialized services for oncology, pharmacometrics, drug development consulting, GMO solutions, liver disease, infectious diseases, vaccines, and orphan/rare diseases. It focuses on clinical and regulatory strategy to assist biotechnology companies in conducting early-phase clinical trials.

Website: novotech-cro.com
Social
Registered Address: CLEMENCEAU AVENUE Pincode : 239920

Key Metrics

Founded Year

2002

Location

Sydney, Australia

Stage

Acquired

Total Funding

$255M in 5 rounds

Latest Funding Round

Seed, Mar 31, 2025, $*****

Last Known Valuation

$***** as on Jan 19, 2022

Investors

GIC & 6 more

Ranked

1^st among 162 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2024

Employee Count

2,148 as on Jun 30, 2026

Investment & Acquisitions

EastHORN Clinical Services & 3 more

Similar Companies

Concert AI & 187 more

Exit Details

Acquired by TPG (Aug 20, 2017)

View Novotech's full profile

Novotech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NOVOTECH HEALTH HOLDINGS PTE. LTD. CIN: 202006336N , Singapore, Active	Feb 24, 2020	$100M - $500M (As on Dec 31, 2024)	-

Novotech got acquired by TPG on Aug 20, 2017.

Click here to take a look at Novotech's acquisition in detail

Novotech has raised a total funding of $255M over 5 rounds. Its first funding round was on Apr 30, 2013. Its latest funding round was a Seed round on Mar 31, 2025 for $*****. 3 investors participated in its latest round. Novotech has 7 institutional investors.

Here is the list of recent funding rounds of Novotech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 31, 2025	9998142	Seed	2354540	3402917	2588620	8561334
Jan 19, 2022	8152446	PE	5448388	7429412	5834866	9959306
Jan 19, 2022	4284612	Conventional Debt	1304618	5722131	3535181	6740635

Access funding benchmarks and valuations. Sign up today!

View details of Novotech's funding rounds and investors

Novotech's employee count trend

Novotech has 2,148 employees as of Jun 26. Here is Novotech's employee count trend over the years:

Uncover Novotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Novotech include Concert AI, Bioptimus and Dotmatics. Here is the list of Top 10 competitors of Novotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novotech 2002, Sydney (Australia), Acquired	Provider of clinical research services across all trial phases and therapeutic areas	$255M	GIC, Mubadala & 5 others	68/100
2nd	Concert AI 2018, Boston (United States), Series C	Provider of AI and real-world data solutions for life sciences	$300M	Sixth Street, Declaration Partners & 4 others	64/100
3rd	Bioptimus 2024, Paris (France), Series A	Developer of AI foundation model to transform biological research	$76M	Cathay Innovation, Sofinnova Partners & 15 others	62/100
4th	Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired	AI powered scientific data management and workflow automation solutions	$11.3M	Scottish Equity Partners, Insight Partners ... & 4 others	62/100
5th	Sygnature Discovery 2004, Nottingham (United Kingdom), Series A	Provider of services and products for integrated drug discovery	-	Rothschild & Co, Torreal & 4 others	56/100
6th	Digital Science 2010, London (United Kingdom), Funding Raised	Research assistance software solutions	-	HHS	56/100
7th	Doctor Evidence 2004, Santa Monica (United States), Acquired	Evidence based medical decision solutions for multiple healthcare stakeholders	$1.5M	Wormhole Capital, Costella Kirsch	56/100
8th	Instem 1969, Conshohocken (United States), Acquired	Software solutions for data collection, management, and analysis for the life science industry	-	Eiffel Investment Group, Europa & 1 others	55/100
9th	Intelligencia 2018, New York City (United States), Series A	Cloud and AI-led analytics platform for drug discovery and development	$13.8M	MTIP, By The Tower & 5 others	52/100
10th	Anju Software 2015, New York City (United States), Acquired	Life science software platform	$27.4M	Providence Equity Partners, PSG	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Novotech's competitors? Click here to see the top ones

Novotech has made 1 investments in companies including Obvio Health. Novotech has also acquired 3 companies including EastHORN Clinical Services and Ncgs.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jan 09, 2023	Acquisition	EastHORN Clinical Services	2004	Prague (Czech Republic)
May 04, 2022	Acquisition	Ncgs	1984	Charleston (United States)
Jul 01, 2021	Investments	Obvio Health	2015	Orlando (United States)